New Zealand markets closed

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
5.83-0.36 (-5.82%)
At close: 04:00PM EST
5.76 -0.07 (-1.20%)
After hours: 07:23PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.71B
Enterprise value 2.43B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-57.78%
S&P500 52-week change 314.07%
52-week high 316.47
52-week low 35.68
50-day moving average 39.04
200-day moving average 311.66

Share statistics

Avg vol (3-month) 32.47M
Avg vol (10-day) 33.35M
Shares outstanding 5180.41M
Implied shares outstanding 6477.14M
Float 8139.11M
% held by insiders 14.30%
% held by institutions 186.19%
Shares short (30 Dec 2021) 427.44M
Short ratio (30 Dec 2021) 412.82
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 415.21%
Shares short (prior month 29 Nov 2021) 427.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin -3.81%
Operating margin (ttm)0.64%

Management effectiveness

Return on assets (ttm)0.43%
Return on equity (ttm)-18.20%

Income statement

Revenue (ttm)1.46B
Revenue per share (ttm)8.51
Quarterly revenue growth (yoy)100.20%
Gross profit (ttm)162.1M
EBITDA 45.89M
Net income avi to common (ttm)-55.6M
Diluted EPS (ttm)-0.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)208.91M
Total cash per share (mrq)1.16
Total debt (mrq)927.14M
Total debt/equity (mrq)108.06
Current ratio (mrq)3.33
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-79.69M
Levered free cash flow (ttm)-84.84M